This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Barun K De: Innovator in Recombinant Protein Technology
Introduction
Barun K De is a notable inventor based in Snellville, GA (US). He has made significant contributions to the field of recombinant protein technology, particularly in the development of lipidated PsaA proteins. With a total of 2 patents to his name, his work has implications for immunological compositions and vaccine development.
Latest Patents
One of Barun K De's latest patents is focused on recombinant lipidated PsaA proteins and the methods of their preparation and use. This invention relates to the expression of lipidated PsaA proteins through recombinant constructs. The lipidation process is achieved using a heterologous leader sequence derived from the ospA gene, which is joined in translational reading frame with the psaA structural gene. The patent also outlines methods for preparing lipidated PsaA proteins and their applications in immunological compositions. Additionally, it provides insights into vaccines that comprise immunogenic lipidated PsaA proteins, along with methods for their use in the prevention and treatment of infections.
Career Highlights
Barun K De is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization highlights his commitment to advancing health-related technologies and innovations.
Collaborations
Throughout his career, Barun K De has collaborated with notable colleagues, including Edwin W Ades and George M Carlone. These collaborations have likely contributed to the success and impact of his inventions.
Conclusion
Barun K De's innovative work in recombinant lipidated PsaA proteins showcases his dedication to advancing medical science. His contributions are vital for the development of effective vaccines and immunological treatments.
